Frequently, drug research has focused on tiny molecules, but peptidic alliances are progressively receiving attention. This new approach involves combining short amino acid chains with complementary medicinal techniques to tackle challenging illness pathways. By utilizing the unique characteristics of peptides – such as high selectivity and bioav